{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:36:25Z","timestamp":1789468585967,"version":"build-2803163510"},"reference-count":69,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Introduction Perceptions of cannabis as a potential medical treatment for\n                    mood and anxiety disorders have been increasing in the context of legalizations,\n                    availability, and medical cannabis programs, though current evidence\n                    predominately indicates risks and negative effects of cannabis use (CU) on\n                    mental health outcomes. This study aims to understand motivations, perceptions,\n                    effects, and patterns of CU in individuals with mood and anxiety disorders.<\/jats:p>\n                  <jats:p>Methods Thirty-six adult patients diagnosed with mood or anxiety\n                    disorders, obsessive-compulsive disorder, or posttraumatic stress disorder who\n                    were currently using cannabis completed an in-depth qualitative interview on\n                    individual motivations, perceptions, experiences, effects, and patterns of their\n                    CU. The thematic analysis focused on phases of CU and sources of cannabis\n                    products and information.<\/jats:p>\n                  <jats:p>Results Reported motivations for initiation of CU included curiosity, peer\n                    pressure, and dissatisfaction with conventional treatments. Factors such as\n                    psychotropic effects and coping with mental health symptoms and insomnia\n                    contributed to the continuation of CU. More negative effects, including\n                    cognitive dysfunction, worsening of mood, and anxiety symptoms, were\n                    acknowledged with ongoing CU. Concerning findings included common initiation of\n                    CU before age 18, combined medical and recreational CU, rare consultation of\n                    medical professionals on CU, and potential effects and harms.<\/jats:p>\n                  <jats:p>Discussion Findings indicate individual complexity of motivations,\n                    perceptions, and patterns of CU in the study population. The reported potential\n                    beneficial effects of specific cannabis products should be further investigated.\n                    Findings emphasize patient-provider dialogue on both CU and conventional\n                    treatments. Information from this study can contribute to and inform the\n                    development of education, prevention, and intervention strategies.<\/jats:p>","DOI":"10.1055\/a-2264-1047","type":"journal-article","created":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T19:57:22Z","timestamp":1710187042000},"page":"141-151","source":"Crossref","is-referenced-by-count":11,"title":["Perceptions, Experiences, and Patterns of Cannabis Use in Individuals\n                    with Mood and Anxiety Disorders in the Context of Cannabis Legalization and\n                    Medical Cannabis Program in Canada \u2013 A Qualitative Study"],"prefix":"10.1055","volume":"57","author":[{"given":"Ankita","family":"Das","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto,\n                    Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Hendershot","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Bowles Center for Alcohol Studies,\n                    University of North Carolina at Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.Ishrat","family":"Husain","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto,\n                    Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto,\n                    Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto,\n                    Toronto, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction\n                    and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Knyahnytska","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto,\n                    Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Elsaid","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto,\n                    Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto,\n                    Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto,\n                    Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto,\n                    Toronto, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction\n                    and Mental Health, Toronto, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto,\n                    Toronto, Canada"},{"name":"Waypoint Research Institute, Waypoint Centre for Mental Health Care,\n                    Penetanguishene, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kloiber","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, University of Toronto, Toronto,\n                    Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto,\n                    Canada"},{"name":"Centre for Addiction and Mental Health, Toronto, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto,\n                    Toronto, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction\n                    and Mental Health, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,3,11]]},"reference":[{"key":"ref2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13011-023-00550-1","article-title":"Youth cannabis use in Canada post-legalization: service providers\u2019 perceptions,\n                    practices, and recommendations","volume":"18","author":"T Kourgiantakis","year":"2023","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e0271079","DOI":"10.1371\/journal.pone.0271079","article-title":"Lessons from 20 years of medical cannabis use in Canada","volume":"18","author":"M Shim","year":"2023","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"H V Curran","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced\n                    psychotic symptoms","volume":"75","author":"M A Bloomfield","year":"2014","journal-title":"Biol Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and cannabis use disorder","volume":"7","author":"J P Connor","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00406-018-0970-7","article-title":"Cannabis and mental illness: A review","volume":"269","author":"DJ E Lowe","year":"2019","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/schbul\/sbw003","article-title":"Meta-analysis of the association between the level of cannabis use and risk of\n                    psychosis","volume":"42","author":"A Marconi","year":"2016","journal-title":"Schizophr Bull"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuroimage.2017.12.041","article-title":"Adolescent cannabis use and brain systems supporting adult working memory\n                    encoding, maintenance, and retrieval","volume":"169","author":"B Tervo-Clemmens","year":"2018","journal-title":"Neuroimage"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-010-1805-z","article-title":"Altered parahippocampal functioning in cannabis users is related to the\n                    frequency of use","volume":"209","author":"B Becker","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1162\/jocn_a_00156","article-title":"Effects of \u03949-tetrahydrocannabinol administration on human encoding and recall\n                    memory function: A pharmacological FMRI study","volume":"24","author":"M G Bossong","year":"2012","journal-title":"J Cogn Neurosci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2174\/13816128113199990436","article-title":"Acute and non-acute effects of cannabis on human memory function: A critical\n                    review of neuroimaging studies","volume":"20","author":"M G Bossong","year":"2014","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/0706743720952251","article-title":"Cannabis use and prospective long-term association with anxiety: A systematic\n                    review and meta-analysis of longitudinal studies","volume":"66","author":"S Xue","year":"2012","journal-title":"Can J Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/cpt.108","article-title":"Cannabis in cancer care","volume":"97","author":"D I Abrams","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","article-title":"Medical cannabis use is associated with decreased opiate medication use in a\n                    retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"K F Boehnke","year":"2016","journal-title":"J Pain"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000176753.45410.8b","article-title":"Randomized, controlled trial of cannabis-based medicine in central pain in\n                    multiple sclerosis","volume":"65","author":"D J Rog","year":"2005","journal-title":"Neurology"},{"key":"ref19","first-page":"Cd009464","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving\n                    chemotherapy","volume":"2015","author":"L A Smith","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1191\/1352458504ms1082oa","article-title":"Do cannabis-based medicinal extracts have general or specific effects on\n                    symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled\n                    study on 160 patients","volume":"10","author":"D T Wade","year":"2004","journal-title":"Mult Scler"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s40429-018-0214-y","article-title":"Cannabis and mood disorders","volume":"5","author":"A M Lucatch","year":"2018","journal-title":"Curr Addict Rep"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1017\/S0033291717003658","article-title":"Developmental sensitivity to cannabis use patterns and risk for major depressive\n                    disorder in mid-life: Findings from 40 years of follow-up","volume":"48","author":"T Schoeler","year":"2018","journal-title":"Psychol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.psychres.2012.12.014","article-title":"Bipolar disorder and co-occurring cannabis use disorders: characteristics,\n                    co-morbidities and clinical correlates","volume":"209","author":"S Lev-Ran","year":"2013","journal-title":"Psychiatry Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2017.02.027","article-title":"Cannabis use and the course and outcome of major depressive disorder: A\n                    population based longitudinal study","volume":"251","author":"D Feingold","year":"2017","journal-title":"Psychiatry Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4088\/JCP.v69n0404","article-title":"Prevalence, correlates, disability, and comorbidity of DSM-IV borderline\n                    personality disorder: Results from the Wave 2 National Epidemiologic Survey on\n                    Alcohol and Related Conditions","volume":"69","author":"B F Grant","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.comppsych.2015.10.003","article-title":"Demographic and clinical characteristics associated with comorbid cannabis use\n                    disorders (CUDs) in hospitalized patients with bipolar I disorder","volume":"65","author":"L M Weinstock","year":"2016","journal-title":"Compr Psychiatry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.addbeh.2017.03.023","article-title":"Symptoms of obsessive-compulsive disorder predict cannabis misuse","volume":"72","author":"A Spradlin","year":"2017","journal-title":"Addict Behav"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1037\/0022-3514.69.5.990","article-title":"Drinking to regulate positive and negative emotions: a motivational model of\n                    alcohol use","volume":"69","author":"M L Cooper","year":"1995","journal-title":"J Pers Soc Psychol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1037\/0021-843X.97.2.168","article-title":"A motivational model of alcohol use","volume":"97","author":"W M Cox","year":"1988","journal-title":"J Abnorm Psychol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/10826086909062040","article-title":"A scale to differentiate between types of smoking as related to the management\n                    of affect","volume":"4","author":"F F Ikard","year":"1969","journal-title":"Int J Addict"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2307\/2344953","article-title":"The classification of smoking by factorial structure of motives","volume":"137","author":"MA H Russell","year":"1974","journal-title":"J R Stat Soc Ser A"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0005-7967(95)00036-W","article-title":"Examination of a three-dimensional drinking motives questionnaire in a young\n                    adult university student sample","volume":"34","author":"S H Stewart","year":"1996","journal-title":"Behav Res Ther"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0191-8869(00)00213-0","article-title":"Negative-reinforcement drinking motives mediate the relation between anxiety\n                    sensitivity and increased drinking behavior","volume":"31","author":"S H Stewart","year":"2001","journal-title":"Pers Individ Dif"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1023\/B:COTR.0000045559.73958.89","article-title":"Evaluating the role of anxiety sensitivity in smoking outcome expectancies among\n                    regular smokers","volume":"28","author":"M J Zvolensky","year":"2004","journal-title":"Cognit Ther Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drugpo.2013.08.010","article-title":"Cannabis for therapeutic purposes: Patient characteristics, access, and reasons\n                    for use","volume":"24","author":"Z Walsh","year":"2013","journal-title":"Int J Drug Policy"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/02791072.2014.920118","article-title":"Marijuana, expectancies, and post-traumatic stress symptoms: A preliminary\n                    investigation","volume":"46","author":"M Earleywine","year":"2014","journal-title":"J Psychoactive Drugs"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/0091450915570309","article-title":"PTSD and cannabis-related coping among recent veterans in New York city","volume":"42","author":"L Elliott","year":"2015","journal-title":"Contemp Drug Probl"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1521-0391.2011.00171.x","article-title":"Cannabis expectancies in substance misusers: French validation of the Marijuana\n                    Effect Expectancy Questionnaire","volume":"20","author":"E Guillem","year":"2011","journal-title":"Am J Addict"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1037\/adb0000210","article-title":"The mediating roles of coping, sleep, and anxiety motives in cannabis use and\n                    problems among returning veterans with PTSD and MDD","volume":"30","author":"J Metrik","year":"2016","journal-title":"Psychol Addict Behav"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/00952990.2013.821477","article-title":"Self-reported cannabis use characteristics, patterns and helpfulness among\n                    medical cannabis users","volume":"40","author":"M O Bonn-Miller","year":"2014","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/dar.12534","article-title":"Health conditions and motivations for marijuana use among young adult medical\n                    marijuana patients and non-patient marijuana users","volume":"37","author":"S E Lankenau","year":"2018","journal-title":"Drug Alcohol Rev"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"152188","DOI":"10.1016\/j.comppsych.2020.152188","article-title":"Overlapping patterns of recreational and medical cannabis use in a large\n                    community sample of cannabis users","volume":"102","author":"J Turna","year":"2020","journal-title":"Compr Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/jgs.15507","article-title":"Characteristics and patterns of marijuana use in community-dwelling older\n                    adults","volume":"66","author":"I R Reynolds","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): A 32-item\n                    checklist for interviews and focus groups","volume":"19","author":"A Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2018.04.054","article-title":"A naturalistic examination of the perceived effects of cannabis on negative\n                    affect","volume":"235","author":"C Cuttler","year":"2018","journal-title":"J Affect Disord"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: Patterns of use and\n                    perceived efficacy","volume":"1","author":"M Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00213-021-06047-8","article-title":"Prevalence and self-reported reasons of cannabis use for medical purposes in USA\n                    and Canada","volume":"239","author":"J Leung","year":"2022","journal-title":"Psychopharmacology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15288\/jsad.2009.70.279","article-title":"Development and preliminary validation of a comprehensive marijuana motives\n                    questionnaire","volume":"70","author":"C M Lee","year":"2009","journal-title":"J Stud Alcohol Drugs"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.addbeh.2006.09.010","article-title":"Marijuana motives: Young adults\u2019 reasons for using marijuana","volume":"32","author":"C M Lee","year":"2007","journal-title":"Addict Behav"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2466\/pr0.2001.89.2.363","article-title":"Substance use among Iranian psychiatric inpatients","volume":"89","author":"J Ahmadi","year":"2001","journal-title":"Psychol Rep"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.drugalcdep.2007.08.005","article-title":"Likelihood of developing an alcohol and cannabis use disorder during youth:\n                    Association with recent use and age","volume":"92","author":"K C Winters","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis: Longitudinal\n                    prospective study","volume":"325","author":"L Arseneault","year":"2002","journal-title":"BMJ"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.copsyc.2020.07.006","article-title":"A review investigating the relationship between cannabis use and adolescent\n                    cognitive functioning","volume":"38","author":"E Cyrus","year":"2021","journal-title":"Curr Opin Psychol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1192\/bjp.bp.110.077479","article-title":"Cannabis use before age 15 and subsequent executive functioning","volume":"198","author":"M A Fontes","year":"2011","journal-title":"Br J Psychiatry"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamapsychiatry.2018.4500","article-title":"Association of cannabis use in adolescence and risk of depression, anxiety, and\n                    suicidality in young adulthood: A systematic review and meta-analysis","volume":"76","author":"G Gobbi","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: A\n                    systematic review","volume":"370","author":"T H Moore","year":"2007","journal-title":"Lancet"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2215-0366(14)70307-4","article-title":"Young adult sequelae of adolescent cannabis use: An integrative analysis","volume":"1","author":"E Silins","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2014.11.009","article-title":"Cannabis and adolescent brain development","volume":"148","author":"D I Lubman","year":"2015","journal-title":"Pharmacol Ther"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamapsychiatry.2018.0335","article-title":"Association of cannabis with cognitive functioning in adolescents and young\n                    adults: A systematic review and meta-analysis","volume":"75","author":"J C Scott","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.addbeh.2011.01.018","article-title":"Predicting adolescent substance use: The effects of depressed mood and positive\n                    expectancies","volume":"36","author":"H K Clark","year":"2011","journal-title":"Addict Behav"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/ADM.0000000000000010","article-title":"Cannabis use expectancies mediate the relation between depressive symptoms and\n                    cannabis use among cannabis-dependent veterans","volume":"8","author":"S G Farris","year":"2014","journal-title":"J Addict Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and\n                    2012-2013","volume":"72","author":"D S Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"N D Volkow","year":"2014","journal-title":"N Engl J Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.11.004","article-title":"P\u00e9rez de los Cobos J, Hasin DS et al. Probability and predictors of transition\n                    from first use to dependence on nicotine, alcohol, cannabis, and cocaine:\n                    results of the National Epidemiologic Survey on Alcohol and Related Conditions\n                    (NESARC)","volume":"115","author":"C Lopez-Quintero","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.smrv.2014.02.005","article-title":"The effects of cannabinoid administration on sleep: A systematic review of human\n                    studies","volume":"18","author":"P J Gates","year":"2014","journal-title":"Sleep Med Rev"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/0706743719895195","article-title":"Cannabidiol as a treatment for mood disorders: A systematic review","volume":"5","author":"J V Pinto","year":"2020","journal-title":"Can J Psychiatry 6"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/1516-4446-2017-0015","article-title":"Cannabidiol presents an inverted U-shaped dose-response curve in a simulated\n                    public speaking test","volume":"41","author":"I M Linares","year":"2019","journal-title":"Braz J Psychiatry"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: From an inactive cannabinoid to a drug with wide spectrum of\n                    action","volume":"30","author":"A W Zuardi","year":"2008","journal-title":"Braz J Psychiatry"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0033291711001322","article-title":"Sub-chronic impact of cannabinoids in street cannabis on cognition,\n                    psychotic-like symptoms and psychological well-being","volume":"42","author":"C J Morgan","year":"2012","journal-title":"Psychol Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.schres.2011.04.017","article-title":"Cannabis with high cannabidiol content is associated with fewer psychotic\n                    experiences","volume":"130","author":"C D Schubart","year":"2011","journal-title":"Schizophr Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/jps.20574","article-title":"Evaluation of a vaporizing device (Volcano) for the pulmonary administration of\n                    tetrahydrocannabinol","volume":"95","author":"A Hazekamp","year":"2006","journal-title":"J Pharm Sci"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"e2124511","DOI":"10.1001\/jamanetworkopen.2021.24511","article-title":"Analysis of state cannabis laws and dispensary staff recommendations to adults\n                    purchasing medical cannabis","volume":"4","author":"J S Merlin","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2264-1047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T05:58:50Z","timestamp":1730786330000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2264-1047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,11]]},"references-count":69,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2024,5,7]]},"published-print":{"date-parts":[[2024,5]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2264-1047","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"value":"0176-3679","type":"print"},{"value":"1439-0795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,11]]}}}